Abridge vs Accolade

Side-by-side comparison of AI visibility scores, market position, and capabilities

Abridge leads in AI visibility (41 vs 25)
Abridge logo

Abridge

EmergingHealthcare

General

Pittsburgh ambient clinical AI (founded by cardiologist) at $5.3B valuation Jun 2025; $800M total ($300M a16z/Khosla Series E) deployed at UPMC 12K clinicians, Mayo Clinic, Johns Hopkins competing with Nuance DAX for physician documentation.

AI VisibilityBeta
Overall Score
C41
Category Rank
#777 of 1158
AI Consensus
50%
Trend
up
Per Platform
ChatGPT
35
Perplexity
49
Gemini
33

About

Abridge is a Pittsburgh, Pennsylvania-based healthcare AI clinical documentation platform — backed with approximately $800 million in total funding including a $300 million Series E in June 2025 led by Andreessen Horowitz and Khosla Ventures at a $5.3 billion valuation, following a $250 million Series D just four months prior at a $2.8 billion valuation — providing physicians, nurses, and care teams at 150+ health systems with AI that automatically converts patient-clinician conversations into structured clinical notes, saving physicians an average of 3 hours daily and generating high-quality documentation from UPMC (scaling to 12,000 clinicians enterprise-wide), Mayo Clinic, Johns Hopkins, and Emory Healthcare. Abridge's AI is trained on a proprietary dataset of over 1.5 million medical encounters, delivering specialty-specific documentation through deep Epic EHR integration. Founded in 2018 by cardiologist Dr. Shiv Rao.

Full profile
Accolade logo

Accolade

GrowthHealthcare

Health Advocacy Platform

Accolade is a personalized health and benefits navigation platform that provides employers with dedicated health assistants who help employees navigate care and benefits.

AI VisibilityBeta
Overall Score
D25
Category Rank
#1 of 1
AI Consensus
75%
Trend
up
Per Platform
ChatGPT
28
Perplexity
23
Gemini
24

About

Accolade is a publicly traded health advocacy company founded in 2007 that provides employers with a personalized health and benefits assistance platform combining human health assistants with data analytics and clinical expertise. The company's advocates help employees understand their benefits, find appropriate providers, navigate complex diagnoses, and access mental health support through a high-touch model that traditional health plan member services cannot match. Accolade serves large employers as a white-labeled benefit that creates a personalized experience for each employee, with advocates who maintain ongoing relationships rather than routing calls to anonymous call centers. The company is publicly traded on Nasdaq under ACCD and has acquired PlushCare, a virtual primary care platform, and 2nd.MD, an expert medical opinion service, to integrate clinical care alongside navigation. Accolade has demonstrated measurable ROI for employer customers through reduced emergency department visits, better management of chronic conditions, and improved benefits utilization. The company serves over 3 million covered lives and positions itself as a whole-person health solution that improves outcomes while lowering costs for self-insured employers.

Full profile

AI Visibility Head-to-Head

41
Overall Score
25
#777
Category Rank
#1
50
AI Consensus
75
up
Trend
up
35
ChatGPT
28
49
Perplexity
23
33
Gemini
24
51
Claude
21
38
Grok
17

Key Details

Category
General
Health Advocacy Platform
Tier
Emerging
Growth
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Accolade
Health Advocacy Platform

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.